Trials / Completed
CompletedNCT00547352
Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection
Switching From Sildenafil Citrate to Tadalafil in Treatment of Erectile Dysfunction: Assessment of Treatment Preference
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tadalafil | 20 mg tadalafil tablets taken by mouth, as needed, no more than once a day for 8 weeks. |
| DRUG | sildenafil | Current users of sildenafil citrate for a minimum of 6 weeks prior to visit 1 will continue with an individual dosage to be taken no more than once a day for an additional 4 weeks. |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-06-01
- First posted
- 2007-10-22
- Last updated
- 2007-10-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00547352. Inclusion in this directory is not an endorsement.